Literature DB >> 9733891

Suppression of c-Myc-induced apoptosis by the Epstein-Barr virus gene product BHRF1.

A Fanidi1, D C Hancock, T D Littlewood.   

Abstract

Constitutive expression of the c-myc proto-oncogene in growth factor-deprived fibroblasts promotes proliferation and induces apoptosis. In these cells, apoptosis can be inhibited by survival factors such as insulin-like growth factor I or the bcl-2 proto-oncogene product. Deregulated c-Myc expression is a common feature in Epstein-Barr virus-positive Burkitt's lymphoma in which the c-myc gene is reciprocally translocated and placed under the control of one of the immunoglobulin loci. BHRF1 is an Epstein-Barr virus protein expressed early in the lytic cycle. BHRF1 is a member of the Bcl-2 family and has been shown to suppress apoptosis and to increase cell survival in different settings. In the present study, we report that BHRF1 inhibits c-Myc-induced apoptosis which occurs in the absence of survival factors. It does not, however, affect the capacity of c-Myc to promote cell growth. These findings demonstrate that BHRF1 has not only structural but also functional similarities to Bcl-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733891      PMCID: PMC110225     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

Review 2.  Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors.

Authors:  G Klein
Journal:  Genes Chromosomes Cancer       Date:  1989-09       Impact factor: 5.006

3.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

Authors:  M L Cleary; S D Smith; J Sklar
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

4.  Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation.

Authors:  Y Hu; M A Benedict; D Wu; N Inohara; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

Authors:  M L Cleary; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.

Authors:  M Eilers; D Picard; K R Yamamoto; J M Bishop
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

7.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

8.  Involvement of the bcl-2 gene in human follicular lymphoma.

Authors:  Y Tsujimoto; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  11 in total

1.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.

Authors:  Dinesh Verma; Chen Ling; Eric Johannsen; Tirumuru Nagaraja; Sankar Swaminathan
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

3.  Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins.

Authors:  David S Bellows; Melanie Howell; Colin Pearson; Sheila A Hazlewood; J Marie Hardwick
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

Authors:  Ami Watanabe; Seiji Maruo; Taku Ito; Miho Ito; Koichi Ricardo Katsumura; Kenzo Takada
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

5.  BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2.

Authors:  A M Flanagan; A Letai
Journal:  Cell Death Differ       Date:  2007-12-14       Impact factor: 15.828

6.  EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.

Authors:  Marc Kvansakul; Martin Rowe; Gemma L Kelly; Leah Fitzsimmons; Rachel Cartlidge; Catherine Chang; Nenad Sejic; Laura C A Galbraith; Chathura D Suraweera; Deborah Croom-Carter; Grant Dewson; Rosemary J Tierney; Andrew I Bell; Clare Shannon-Lowe; Marco J Herold; Alan B Rickinson; Peter M Colman; David C S Huang; Andreas Strasser
Journal:  Cell Death Differ       Date:  2019-10-23       Impact factor: 15.828

Review 7.  How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?

Authors:  Martin J Allday
Journal:  Semin Cancer Biol       Date:  2009-07-25       Impact factor: 15.707

Review 8.  EBV and Apoptosis: The Viral Master Regulator of Cell Fate?

Authors:  Leah Fitzsimmons; Gemma L Kelly
Journal:  Viruses       Date:  2017-11-13       Impact factor: 5.048

9.  Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis.

Authors:  Feixiong Cheng; James L Murray; Junfei Zhao; Jinsong Sheng; Zhongming Zhao; Donald H Rubin
Journal:  PLoS Comput Biol       Date:  2016-09-15       Impact factor: 4.475

10.  A gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivo.

Authors:  Carrie B Coleman; Jennifer E McGraw; Emily R Feldman; Alexa N Roth; Lisa R Keyes; Katrina R Grau; Stephanie L Cochran; Thomas J Waldschmidt; Chengyu Liang; J Craig Forrest; Scott A Tibbetts
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.